2 PhD positions in pharmacology/drug discovery
Walther-Straub-Institut für Pharmakologie und Toxikologie
30.01.2024
We are looking for recent graduates (Master of Science in biology, biochemistry, chemistry, pharmaceutical sciences or similar) who are interested in pharmacology, drug discovery, and CRISPR/Cas/iPSC disease models related to e.g. lysosomal storage and neurodegenerative diseases (Alzheimer, Parkinson, FTD) but also other disease areas. Our molecular target focus is on ion channel and transport proteins in endosomes and lysosomes, in particular in TRPML cation channels (mucolipins) and two-pore channels (TPCs). The candidate would ideally have experience in a wide range of molecular biology techniques including working with CRISPR/Cas9 and, and/or experience in or interest in patch-clamp electrophysiology and imaging techniques. As part of this project the PhD canidate will also cooperate with Proteomics facilities at the LMU. The LMU is one of the top ranked German universities and our department is located in the vibrant center of the city of Munich (Medical campus city).
If you believe you fit this description then please send a brief letter of motivation, a short CV highlighting your academic and research accomplishments as well as copies of academic certificates and recommendation letters to christian.grimm@med.uni-muenchen.de
For more information please check also:
https://www.wsi.med.uni-muenchen.de/forschung/molekulare-pharmakologie/index.html
Downloads
- phd_pharmacology (422 KByte)